InvestorsHub Logo
Followers 45
Posts 6162
Boards Moderated 0
Alias Born 06/17/2009

Re: None

Thursday, 07/18/2019 5:51:44 PM

Thursday, July 18, 2019 5:51:44 PM

Post# of 458949
So, which comes first, the chicken (2-73) or the egg (gut bacteria)?

Unfortunately, IMO, we learned nothing significant about 2-73 yesterday with the AAIC presentation. As someone stated earlier today, the presentation was to highlight Ariana’s capabilities, not Anavex’s positive results. That is why there was no anxiety/hype before this conference. This might be interesting to a gastro-scientist, but not to those looking for quantum leaps in 2-73’s ability to be a remedy/cure for Alzheimer’s. Presentation raised more questions for investors than it answered.

Regardless of this disappointment, if Anavex were the worthless piece of a scumbaggy, non-revenue biotech firm that some posters claim about it and its management, then WHY was Anavex invited to join the Consortium … or if it were Anavex’s idea to bring a consortium together, why did these large, smart, ingenious BP and BP affiliated firms decide to sign on?

I think their decisions (they know MORE than we do) to be involved with Anavex via the Consortium are a better assessment of Anavex’s POTENTIAL than some erstwhile posters on a MB.

P.S. TGD's comment about the iceberg is still meaningful, IMO, but we are seeing less of the iceberg after yesterday's presentation.


ANAVEX NOW … MONO-STYLE … RWEm for Life!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News